Healthcare >> CEO Interviews >> October 26, 2004
DR. HALVOR JAEGER is Chief Executive Officer of LAB International Inc.
After receiving an MD degree from the University of Ulm in Germany in
1976, Dr. Jaeger started a scientific career at this university. In
1979, he founded LAB in Germany and, as its CEO, developed it as of one
of the principal contract research institutes in Germany. In addition,
he lectured on pharmacology for several years. After selling LAB Germany
in 1995 to a worldwide provider of pharmaceutical services, he relocated
to Canada and took over LAB International Canada. After substantial
increase in value, the Phase I/bioanalytical business of the company was
sold to a Toronto-based public company in 1998, and the pharmaceutical
arm to a French company. At that time LAB Pre-clinical was founded as a
new company and taken public in 2002 as a product development company.
The aim of the company is to develop products with substantial funds
being generated through its service business. Dr. Jaeger has written
and/or collaborated on over 100 scientific publications. He acted as
Expert Agree for the French Health Authorities in pharmacokinetics. In
1996, he was appointed Fellow of the American College of Clinical
Pharmacology. Profile
and then a picture of what you are doing at the present time?
Dr. Jaeger: Actually it's a number of companies. I started
